Registration opens for IQ Induction Working Group two-part webinar series in February 2021
January 27, 2021
The IQ Translational and ADME Sciences Leadership Group (TALG) Induction Working Group (IWG) invites you to attend the two-part webinar series based on its two recent publications:
- Perspectives from the Innovation and Quality Consortium Induction Working Group on Factors Impacting Clinical Drug-Drug Interactions Resulting from Induction: Focus on Cytochrome 3A Substrates (Drug Metabolism and Disposition, 2019)
- Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro Cytochrome P450 Induction Studies Including Impact on Drug Interaction Risk Assessment (Drug Metabolism and Disposition, 2021)
This two-part public webinar series serves as an online platform to promote pre-competitive interaction and collaboration among industry-peers. We encourage you to share this with interested peers and colleagues. As a public series, IQ membership is not required for registration.
*Separate registration for each webinar is required.
| Part I: 19 February 2021, 12:00-1:30 PM ET | Part II: 25 February 2021, 12:00-1:00 PM ET | ||
|
Factors Impacting Magnitude of Clinical DDI Due to Induction: Focus on CYP3A Substrates |
Time Course & Model Fitting of CYP Induction Data: Impact on Drug Interaction Risk Assessment |
||
| Speaker: Diane Ramsden, Associate Scientific Director in global DMPK, Takeda | Speaker: Simon Wong, Director, Pliant Therapeutics | ||
|
This webinar will guide the audience through potential contributors to variability in clinical induction response, and highlight areas that may lead to improved extrapolation. |
This webinar will introduce the audience to model-fitting approaches and present recommendations related to the time-course for optimal in vitro induction and the impact on drug-drug interaction risk assessment. |
||
REGISTER HERE for PART I |
REGISTER HERE for PART II |